Stocknear Logo Stocknear
/
Popular
  • KO Coca Cola Company Stock
  • TSLA Tesla Inc Stock
  • AMD Advanced Micro Devices Stock
  • SPY SPDR S&P 500 ETF Trust ETF
  • NVDA Nvidia Stock
    • Login

    DexCom Inc.

    NASDAQ: DXCM · Real-Time Price · USD
    86.66
    0.92 (1.07%)
    At close: Jun 06, 2025, 3:59 PM
    86.00
    -0.76%
    After-hours: Jun 06, 2025, 05:57 PM EDT

    DexCom Statistics

    Share Statistics

    DexCom has 392.11M shares outstanding. The number of shares has increased by -1.74% in one year.

    Shares Outstanding

    n/a
    		 392.11M

    Shares Change (YoY)

    n/a
    		 -1.74%

    Shares Change (QoQ)

    n/a
    		 0.05%

    Owned by Institutions (%)

    n/a
    		 90.39%

    Shares Floating

    n/a
    		 n/a

    Failed to Deliver (FTD) Shares

    n/a
    		 109

    FTD / Avg. Volume

    n/a
    		 n/a

    Short Selling Information

    The latest short interest is 11.28M, so 2.88% of the outstanding shares have been sold short.

    Short Interest

    n/a
    		 11.28M

    Short % of Shares Out

    n/a
    		 2.88%

    Short % of Float

    n/a
    		 3.69%

    Short Ratio (days to cover)

    n/a
    		 2.17

    Valuation Ratios

    The PE ratio is 54.61 and the forward PE ratio is 33.72. DexCom's PEG ratio is 39.32.

    PE Ratio

    n/a
    		 54.61

    Forward PE

    n/a
    		 33.72

    PS Ratio

    n/a
    		 7.8

    Forward PS

    n/a
    		 4.3

    PB Ratio

    n/a
    		 14.97

    P/FCF Ratio

    n/a
    		 49.89

    PEG Ratio

    n/a
    		 39.32
    Financial Ratio History

    Enterprise Valuation

    DexCom has an Enterprise Value (EV) of 33.45B.

    EV / Sales

    n/a
    		 8.29

    EV / EBITDA

    n/a
    		 35.37

    EV / EBIT

    n/a
    		 33.8

    EV / FCF

    n/a
    		 53.03

    Financial Position

    The company has a current ratio of 1.47, with a Debt / Equity ratio of 1.23.

    Current Ratio

    n/a
    		 1.47

    Quick Ratio

    n/a
    		 1.28

    Debt / Equity

    n/a
    		 1.23

    Debt / EBITDA

    n/a
    		 2.74

    Debt / FCF

    n/a
    		 4.1

    Interest Coverage

    n/a
    		 31.58

    Financial Efficiency

    Return on Equity is 27.4% and Return on Invested Capital is 10.2%.

    Return on Equity

    n/a
    		 27.4%

    Return on Assets

    n/a
    		 8.89%

    Return on Invested Capital

    n/a
    		 10.2%

    Revenue Per Employee

    n/a
    		 $395,392.16

    Profits Per Employee

    n/a
    		 $56,490.2

    Employee Count

    n/a
    		 10,200

    Asset Turnover

    n/a
    		 0.62

    Inventory Turnover

    n/a
    		 2.89

    Taxes

    Income Tax

    n/a
    		 132.8M

    Effective Tax Rate

    n/a
    		 18.73%

    Stock Price Statistics

    The stock price has increased by -25.65% in the last 52 weeks. The beta is 1.46, so DexCom's price volatility has been higher than the market average.

    Beta

    n/a
    		 1.46

    52-Week Price Change

    n/a
    		 -25.65%

    50-Day Moving Average

    n/a
    		 75.92

    200-Day Moving Average

    n/a
    		 76.3

    Relative Strength Index (RSI)

    n/a
    		 59.5

    Average Volume (20 Days)

    n/a
    		 4,294,773

    Income Statement

    In the last 12 months, DexCom had revenue of 4.03B and earned 576.2M in profits. Earnings per share was 1.46.

    Revenue

    n/a
    		 4.03B

    Gross Profit

    n/a
    		 2.47B

    Operating Income

    n/a
    		 600M

    Net Income

    n/a
    		 576.2M

    EBITDA

    n/a
    		 945.7M

    EBIT

    n/a
    		 728M

    Earnings Per Share (EPS)

    n/a
    		 1.46
    Full Income Statement

    Balance Sheet

    The company has 606.1M in cash and 2.59B in debt, giving a net cash position of -1.98B.

    Cash & Cash Equivalents

    n/a
    		 606.1M

    Total Debt

    n/a
    		 2.59B

    Net Cash

    n/a
    		 -1.98B

    Retained Earnings

    n/a
    		 1.6B

    Total Assets

    n/a
    		 6.75B

    Working Capital

    n/a
    		 1.52B
    Full Balance Sheet

    Cash Flow

    In the last 12 months, operating cash flow was 989.5M and capital expenditures -358.8M, giving a free cash flow of 630.7M.

    Operating Cash Flow

    n/a
    		 989.5M

    Capital Expenditures

    n/a
    		 -358.8M

    Free Cash Flow

    n/a
    		 630.7M

    FCF Per Share

    n/a
    		 1.56
    Full Cash Flow Statement

    Margins

    Gross margin is 61.14%, with operating and profit margins of 14.88% and 14.29%.

    Gross Margin

    n/a
    		 61.14%

    Operating Margin

    n/a
    		 14.88%

    Pretax Margin

    n/a
    		 17.58%

    Profit Margin

    n/a
    		 14.29%

    EBITDA Margin

    n/a
    		 23.45%

    EBIT Margin

    n/a
    		 14.88%

    FCF Margin

    n/a
    		 15.64%

    Dividends & Yields

    DXCM does not appear to pay any dividends at this time.

    Dividend Per Share

    n/a
    		 n/a

    Dividend Yield

    n/a
    		 n/a

    Dividend Growth (YoY)

    n/a
    		 n/a

    Payout Ratio

    n/a
    		 n/a

    Earnings Yield

    n/a
    		 1.83%

    FCF Yield

    n/a
    		 2%
    Dividend Details

    Analyst Forecast

    The average price target for DXCM is $99, which is 15.5% higher than the current price. The consensus rating is "Buy".

    Price Target

    n/a
    		 $99

    Price Target Difference

    n/a
    		 15.5%

    Analyst Consensus

    n/a
    		 Buy

    Analyst Count

    n/a
    		 19
    Stock Forecasts

    Fair Value

    There are several formulas that can be used to estimate the intrinsic value of a stock.

    Lynch Fair Value

    n/a
    		 $7.3

    Lynch Upside

    n/a
    		 -91.48%

    Graham Number

    n/a
    		 12.9

    Graham Upside

    n/a
    		 -84.95%

    Stock Splits

    The last stock split was on Jun 13, 2022. It was a forward split with a ratio of 4:1.

    Last Split Date

    n/a
    		 Jun 13, 2022

    Split Type

    n/a
    		 forward

    Split Ratio

    n/a
    		 4:1

    Scores

    Altman Z-Score

    n/a
    		 6.15

    Piotroski F-Score

    n/a
    		 6

    Add to Watchlist